CervoMed Inc CRVO
$2.58
▲ +2.38%
(+$0.06)
⬆️ Above Yest. High
🎈 Low Float
🗓️ Earnings Next Week
Open
$2.51
Prev Close
$2.52
Day Range
$2.46 – $2.60
52W Range
$2.13 – $11.25
Market Cap
$34.90M
Beta
-0.60
EPS (TTM)
$-3.27
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2016-11-09 |
| Shares Out. | 13,530,000 |
| Website | cervomed.com/ ↗ |
| Phone | 16177444400 |
| Employees | 15 |
| Net Income | -$8.0M |
| Total Assets | $15.1M |
| Total Liabilities | $4.5M |
| Equity | $10.6M |
About CervoMed Inc
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
CervoMed Inc is a publicly traded company under the ticker symbol CRVO on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
13 analysts (2026-07-01)